ProKidney

Forecast & Rating7 analysts currently cover ProKidney, with about 57.1% giving a positive rating — meaning they expect the stock to rise. The average price target is $6.25, about 316.7% upside from the current price of $1.50. Price targets range from $1.00 to $12.00 — a wide spread, showing clear disagreement over just how much ProKidney can rise. Historically, about 43.4% of past price targets were eventually met, which adds credibility. For you, this means institutional views on ProKidney are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jun 5, 2026; for reference only and not investment advice.